???global.info.a_carregar???
Carla Torre graduated in Pharmaceutical Sciences (PharmD) by the Faculty of Pharmacy of the University of Lisbon, in 2004. She holds a Post-graduate Diploma (PgD) in Pharmacy and Medicinal Products Law by the Faculty of Law of the University of Coimbra (2006) and a Master's degree (MSc) in Epidemiology from the Faculty of Medicine of the University of Porto (2009). In 2018, Carla Torre completed her PhD in Pharmacy, specialization in Pharmacoepidemiology at the Faculty of Pharmacy of the University of Lisbon, where she is currently Assistant Professor (responsible for teaching Pharmacoepidemiology, Pharmacovigilance & Risk Management of Medicines and Health Products at both undergraduate and postgraduate levels). In 2020, Carla Torre concluded the Postgraduate Professional Development course (Certificate of Achievement) in Pharmacoepidemiology and Pharmacovigilance at the London School of Hygiene & Tropical Medicine. Over the years she completed several specialization and training courses (e.g. McGill University - Montreal, Canada; Utrecht University - Utrecht, the Netherlands) in design, conducting, analysis and interpretation of Pharmacoepidemiology, Clinical Trials, Pharmacovigilance and Statistics research. At the Faculty of Pharmacy, she is the co-coordinator of the Master in Regulation and Evaluation of Medicines and Health Products and Vice-President of the Equality, Inclusion and Non-Discrimination Committee. Carla Torre leads the Epidemiology, Pharmacoepidemiology & Pharmacovigilance sub-group of the Laboratory of Systems Integration Pharmacology, Clinical & Regulatory Science at the Research Institute for Medicines hosted at the University of Lisbon.
Read full resume ↓
Identification

Personal identification

Full name
Carla de Matos Torre

Citation names

  • Torre, Carla

Author identifiers

Ciência ID
9F11-9E8F-CDF2
ORCID iD
0000-0002-5542-9993
Google Scholar ID
https://scholar.google.com/citations?user=LC4AJNsAAAAJ&hl=en
Researcher Id
AEU-8159-2022
Scopus Author Id
35724633000

Email addresses

  • carla.torre@ff.ulisboa.pt (Professional)

Addresses

  • Faculdade de Farmácia da Universidade de Lisboa | Avenida Professor Gama Pinto, 1649-003, LISBOA, Lisboa, Portugal (Professional)

Knowledge fields

  • Medical and Health Sciences - Health Sciences - Epidemiology
Education
Degree Classification
2019/09 - 2020/07
Concluded
 Postgraduate Professional Development course in Pharmacoepidemiology and Pharmacovigilance (Postgraduate Certificate)
London School of Hygiene & Tropical Medicine, United Kingdom
2012/02/01 - 2018/06
Concluded
 Farmácia (Doutoramento)
Major in Farmacoepidemiologia
Universidade de Lisboa Faculdade de Farmácia, Portugal
"Intensive monitoring in Portugal: a pharmacy-based model to assess medicines in real-life conditions. The example of new glucose lowering drugs" (THESIS/DISSERTATION)
 Approved with Distinction and Honnor
2007 - 2009/07/27
Concluded
 Epidemiologia (Mestrado)
Universidade do Porto Faculdade de Medicina, Portugal
"Syringe Exchange Programme - The Portuguese Experience." (THESIS/DISSERTATION)
2005/03 - 2006/02
Concluded
 Direito da Farmácia e do Medicamento (Pós-Graduação)
Universidade de Coimbra Faculdade de Direito, Portugal
1998 - 2004
Concluded
 Ciências Farmacêuticas (Mestrado integrado)
Universidade de Lisboa Faculdade de Farmácia, Portugal
Affiliation

Science

Category
Host institution 		Employer
2021/05 - Current Principal Investigator (Research) Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal

Teaching in Higher Education

Category
Host institution 		Employer
2022/09 - Current Assistant Professor (University Teacher) Universidade de Lisboa Faculdade de Farmácia, Portugal
2018/09/03 - 2022/08 Invited Assistant Professor (University Teacher) Universidade de Lisboa Faculdade de Farmácia, Portugal
Universidade de Lisboa Faculdade de Farmácia, Portugal
Projects

Grant

Designation Funders
2023/01/01 - Current More-EUROPA – ‘More Effectively Using Registries to SuppOrt PAtient-Centered Regulatory and HTA Decision-Making
HORIZON-HLTH-2022-TOOL-11-02
Co-Principal Investigator (Co-PI)
Ongoing

Contract

Designation Funders
2019/01/01 - 2019/12/31 Instituto de Investigação do Medicamento
UID/DTP/04138/2019
154706UID
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal

Universidade de Lisboa Faculdade de Farmácia, Portugal
Fundação para a Ciência e a Tecnologia
Concluded
Outputs

Publications

Book chapter
  1. Torre, Carla; Barão, Paula. "Notificação espontânea". In Farmacovigilância em Portugal: 25 anos, 163-176. Portugal: INFARMED, 2018.
    Published
  2. Torre, Carla; Paula, Ana. "Overview of Pharmacoepidemiological Databases in the Assessment of Medicines Under Real-Life Conditions". In Epidemiology - Current Perspectives on Research and Practice, edited by Lunet, Nuno, 131-154. InTech, 2012.
    10.5772/35318
Conference abstract
  1. Marques, Adriana; Ferreira, Paula Sousa; Torre, Carla; Sepodes, Bruno; Rocha, Joao. Corresponding author: Marques, Adriana. "Real-world safety of NTRK inhibitors in colorectal cancer: preliminary results of a 4-year pharmacovigilance study". Paper presented in Congresso Nacional dos Farmacêuticos 2024, Lisbon, 2024.
    Submitted
Conference paper
  1. Torre, Carla; Brazão, Roberto; Guerreiro, José; Gomes, Marta; Costa, Suzete; Oliveira, Luísa; Viegas, Silvia. "Investigação epidemiológica de Toxinfeções Alimentares na Rede de Farmácias Portuguesas: um estudo piloto". 2015.
  2. Torre, Carla; Brazão, Roberto; Guerreiro, José; Gomes, Marta; Costa, Suzete; Oliveira, Luisa; Viegas, Silvia. "Epidemiologic Investigation of Foodborne Outbreaks in Pharmacies: A Pilot Study". 2015.
  3. Torre, Carla; Brazão, Roberto; Guerreiro, José; Gomes, Marta; Costa, Suzete; Oliveira, Luísa; Viegas, Silvia. "Investigação epidemiológica de Toxinfeções Alimentares na Rede de Farmácias Portuguesas: um estudo piloto". 2015.
  4. Viegas, Silvia; Brazão, Roberto; Oliveira, Luísa; Torre, Carla. "Rede Portuguesa sobre Informação Microbiológica de Alimentos (RPIMA): resultados 2014 – GTTA". 2014.
Conference poster
  1. Jorge Monteiro; Almeida, Diogo; João Paulo Fernandes; Sepodes, Bruno; Torre, Carla. "Review of studies evaluating effectiveness of risk minimisation measures for oncology medicinal products registered in the European Medicines Agency (HMA-EMA) Catalogue: findings and lessons learned". Paper presented in Dia da Farmacovigilância 2024 - Farmacovigilância: Rumo a uma Abordagem Integrada, 2024.
  2. Marques, Adriana; Torre, Carla; Pinto, Rui; Sepodes, Bruno; Rocha, Joao. Corresponding author: Marques, Adriana. "Treatment Advances in Sepsis and Septic Shock: Modulating pro- and anti-inflammatory mechanisms (A review)". Paper presented in Simpósio Científico "O Futuro Hoje: Novas Terapêuticas Moleculares e Biológicas” - Ordem dos Farmacêuticos, SRSRA, 2023.
  3. Marques, Adriana; Torre, Carla; Pinto, Rui; Rocha, Joao; Sepodes, Bruno. Corresponding author: Marques, Adriana. "Tumor Mutational Burden in Colorectal Cancer: Implications for Treatment". Paper presented in Simpósio Científico "O Futuro Hoje: Novas Terapêuticas Moleculares e Biológicas” - Ordem dos Farmacêuticos, SRSRA, 2023.
  4. Almeida, Diogo; António Teixeira Rodrigues; Jose Pedro Guerreiro; Ewa Balkowiec-Iskra; Robert Vander Stichele; Sepodes, Bruno; Torre, Carla. "COVID-19 Pandemic and the Consumption of Self-Care Products for Pediculosis Capitis in Portugal: An interrupted time-series analysis". Paper presented in 7th International Conference on Phthiraptera (ICP 7), 2023.
Journal article
  1. Elizabeth M. Curtis; Mario Miguel; Claire McEvoy; Andrea Ticinesi; Carla Torre; Nasser Al-Daghri; Majed Alokail; et al. "Impact of dementia and mild cognitive impairment on bone health in older people". Aging Clinical and Experimental Research (2024): https://doi.org/10.1007/s40520-024-02871-y.
    10.1007/s40520-024-02871-y
  2. Diana Mandslay; Diogo Almeida; Adriana Marques; João Rocha; Frantisek Drafi; Bruno Sepodes; Carla Torre. "Comparative Analysis of Post-Authorization Measures for Advanced Medicinal Products Authorized in the European Union and in the United States of America Between 2009 and 2023". Clinical Pharmacology & Therapeutics (2024): https://doi.org/10.1002/cpt.3410.
    10.1002/cpt.3410
  3. Edna Ribeiro Parracha; António Teixeira Rodrigues; Sofia Oliveira-Martins; Sónia Romano; Diogo Almeida; Bruno Sepodes; Carla Torre. "Pharmacist's role in influenza immunisation: a scoping review". Journal of Pharmacy Practice and Research (2024): https://doi.org/10.1002/jppr.1932.
    10.1002/jppr.1932
  4. Stefanie Prilla; Sophie Groeneveld; Alexandra Pacurariu; María Clara Restrepo-Méndez; Patrice Verpillat; Carla Torre; Christian Gartner; et al. "Real-World Evidence to Support EU Regulatory Decision Making—Results From a Pilot of Regulatory Use Cases". Clinical Pharmacology & Therapeutics (2024): https://doi.org/10.1002/cpt.3355.
    10.1002/cpt.3355
  5. Francesca Cerreta; Ewa Balkowiec Iskra; Amelia Cupelli; Bruno Sepodes; Elina Rönnemaa; Mário Miguel Rosa; Sabine Mayrhofer; et al. "Medicines for an aging population: The EMA perspective and policies". Journal of the American Geriatrics Society (2024): https://doi.org/10.1111/jgs.18953.
    10.1111/jgs.18953
  6. Luísa Bouwman; Bruno Sepodes; Hubert Leufkens; Carla Torre. "Trends in orphan medicinal products approvals in the European Union between 2010–2022". Orphanet Journal of Rare Diseases (2024): http://dx.doi.org/10.1186/s13023-024-03095-z.
    10.1186/s13023-024-03095-z
  7. Almeida, Diogo; Umuhire, Denise; Gonzalez-Quevedo, Rosa; Antonio, Ana; Burgos, Juan Garcia; Verpillat, Patrice; Bere, Nathalie; Sepodes, Bruno; Torre, Carla. "Leveraging patient experience data to guide medicines development, regulation, access decisions and clinical care in the EU". Frontiers in Medicine (2024): https://publons.com/wos-op/publon/68545776/.
    10.3389/FMED.2024.1408636
  8. Patricia García-Abeijon; Catarina Costa; Margarita Taracido; Maria Teresa Herdeiro; Carla Torre; Adolfo Figueiras. "Factors Associated with Underreporting of Adverse Drug Reactions by Health Care Professionals: A Systematic Review Update". Drug Safety (2023): https://doi.org/10.1007/s40264-023-01302-7.
    10.1007/s40264-023-01302-7
  9. Catarina Costa; Patricia Abeijon; Daniela A. Rodrigues; Adolfo Figueiras; Maria Teresa Herdeiro; Carla Torre. "Factors associated with underreporting of adverse drug reactions by patients: a systematic review". International Journal of Clinical Pharmacy (2023): https://doi.org/10.1007/s11096-023-01592-y.
    10.1007/s11096-023-01592-y
  10. Mariana Domingues; Carla Torre; José Pedro Guerreiro; Pedro Barata; Margarida Correia-Neves; João Rocha; Bruno Sepodes; António Teixeira Rodrigues. "COVID-19 pandemic and the quality of antibiotic use in primary care: an interrupted time-series study". International Journal for Quality in Health Care (2023): https://doi.org/10.1093/intqhc/mzad014.
    10.1093/intqhc/mzad014
  11. Adriana Marques; Carla Torre; Rui Pinto; Bruno Sepodes; João Rocha. "Treatment Advances in Sepsis and Septic Shock: Modulating Pro- and Anti-Inflammatory Mechanisms". Journal of Clinical Medicine (2023): https://doi.org/10.3390/jcm12082892.
    10.3390/jcm12082892
  12. Inês Martinho; António Teixeira Rodrigues; José Guerreiro; João Rocha; Bruno Sepodes; Carla Torre. "A cross-country utilization patterns comparison of high expenditure therapeutic groups between Portugal and six European countries: the two sides of the Portuguese coin". Expert Review of Pharmacoeconomics & Outcomes Research (2023): https://doi.org/10.1080/14737167.2023.2144839.
    10.1080/14737167.2023.2144839
  13. Denkinger, Michael; Knol, Wilma; Cherubini, Antonio; Simonds, Anita; Lionis, Christos; Lacombe, Denis; Petelos, Elena; et al. "Inclusion of functional measures and frailty in the development and evaluation of medicines for older adults". The Lancet Healthy Longevity (2023): https://publons.com/wos-op/publon/66105430/.
    10.1016/S2666-7568(23)00208
  14. Carla de Matos Torre. "A review of patient-reported outcomes used for regulatory approval of oncology medicinal products in the European Union between 2017 and 2020". Frontiers in Medicine 9 (2022): http://dx.doi.org/10.3389/fmed.2022.968272.
    10.3389/fmed.2022.968272
  15. Batista, Jorge; Torre, Carla; Sousa Lobo, José Manuel; Sepodes, Bruno. "A review of the continuous professional development system for pharmacists". Human Resources for Health 20 1 (2022): http://hdl.handle.net/10362/147862.
    https://doi.org/10.1186/s12960-021-00700-1
  16. Torre, Carla; Rodrigues, Antonio Teixeira; Domingues, Mariana; Guerreiro, Jose; Rocha, Joao; Sepodes, Bruno. "Does COVID-19 pandemic impacted on quality of antibiotic use in the community? An interrupted time-series analysis". Pharmacoepidemiology and Drug Safety (2022): https://publons.com/wos-op/publon/57446840/.
  17. Santos, Pedro Machado dos; Silva, Cláudia Ribeiro da; Costa, Diana; Torre, Carla. "Burnout in the pharmaceutical activity: the impact of COVID-19". Frontiers in Psychiatry 12 (2022): http://hdl.handle.net/10400.26/40229.
    10.3389/fpsyt.2021.771462
  18. Torre, Carla; Teixeira, Maria Manuel; Borges, Fabio Cardoso; Barao, Paula; Rocha, Joao; Sepodes, Bruno. "A review of patient-reported outcomes for European medicines agency regulatory approval of oncologic drugs between 2017 and 2020". Pharmacoepidemiology and Drug Safety (2022): https://publons.com/wos-op/publon/57446844/.
  19. Torre, Carla; Costa, Catarina Rego; Abeijon, Patricia; Figueiras, Adolfo; Herdeiro, Maria. "Factors associated with under-reporting of adverse drug reactions: A systematic review". Pharmacoepidemiology and Drug Safety (2022): https://publons.com/wos-op/publon/56162028/.
  20. Rodrigues, Antonio Teixeira; Guerreiro, Jose; Torre, Carla. "Group-based trajectory modeling of medication refill patterns of novel oral anticoagulant (NOACS): An analysis of the phollow cohort". Pharmacoepidemiology and Drug Safety (2022): https://publons.com/wos-op/publon/58780159/.
  21. "Overtreatment and undertreatment in a sample of elderly people with diabetes". International Journal of Clinical Practice 75 11 (2021): http://dx.doi.org/10.1111/ijcp.14847.
    10.1111/ijcp.14847
  22. Rafael Amaral; Carla Torre; João Rocha; Bruno Sepodes. "Ebola outbreaks: A stress test of the preparedness of medicines regulatory systems for public health crises". Drug Discovery Today (2021): https://doi.org/10.1016/j.drudis.2021.06.019.
    10.1016/j.drudis.2021.06.019
  23. "Implementation and Access to Pre-exposure Prophylaxis for Human Immunodeficiency Virus by Men Who Have Sex With Men in Europe". Frontiers in Medicine 8 (2021): http://dx.doi.org/10.3389/fmed.2021.722247.
    10.3389/fmed.2021.722247
  24. AL-Musawe, L.; Torre, C.; Guerreiro, J.P.; Rodrigues, A.T.; Raposo, J.F.; Mota-Filipe, H.; Martins, A.P.. "Drug-drug interactions and inappropriate medicines impact on glycemic control and kidney function in older adults with diabetes-attending specialty care institution". European Journal of Clinical Pharmacology 77 9 (2021): 1397-1407. http://www.scopus.com/inward/record.url?eid=2-s2.0-85103149266&partnerID=MN8TOARS.
    10.1007/s00228-021-03107-y
  25. Martinho, Ines; Guerreiro, Jose; Teixeira-Rodrigues, Antonio; Torre, Carla. "Optimization of prescription patterns: A response to control high pharmaceutical expenditure". Pharmacoepidemiology and Drug Safety (2021): https://publons.com/wos-op/publon/51988443/.
  26. C. Torre; J. Guerreiro; P. Longo; J. F. Raposo; H. Leufkens; A. P. Martins. "Intensive monitoring of adverse drug events associated with the use of new glucose-lowering drugs: results from an inception cohort study in Portugal". Diabetic Medicine (2020): https://doi.org/10.1111/dme.14168.
    10.1111/dme.14168
  27. AL-Musawe, L.; Torre, C.; Guerreiro, J.P.; Rodrigues, A.T.; Raposo, J.F.; Mota-Filipe, H.; Martins, A.P.; et al. "Polypharmacy, potentially serious clinically relevant drug-drug interactions, and inappropriate medicines in elderly people with type 2 diabetes and their impact on quality of life". Pharmacology Research and Perspectives 8 4 (2020): http://www.scopus.com/inward/record.url?eid=2-s2.0-85087474684&partnerID=MN8TOARS.
    10.1002/prp2.621
  28. Parreira, Ana Isabel; Ferreira, Paula Sousa; Martins, Ana Paula; Torre, Carla. "Spontaneous reporting of adverse drug reactions by patients: a comparative study between European countries". Pharmacoepidemiology and Drug Safety (2020): https://publons.com/wos-op/publon/51988445/.
  29. Nieto, Margarida; Ferreira, Paula Sousa; Martins, Ana Paula; Torre, Carla. "The role of the Portuguese patients' associations in the pharmacovigilance system". Pharmacoepidemiology and Drug Safety (2020): https://publons.com/wos-op/publon/51988444/.
  30. Torre, Carla. "The association between polypharmacy and adverse health consequences in elderly type 2 diabetes mellitus patients; a systematic review and meta-analysis". Diabetes Research and Clinical Practice (2019): http://dx.doi.org/10.1016/j.diabres.2019.107804.
    10.1016/j.diabres.2019.107804
  31. Torre C; Cary M; Borges FC; Ferreira PS; Alarcão J; Leufkens HG; Costa J; Martins AP. "Intensive Monitoring Studies for Assessing Medicines: A Systematic Review.". Frontiers in medicine (2019): http://europepmc.org/abstract/med/31380375.
    10.3389/fmed.2019.00147
  32. Torre, C.; Guerreiro, J.; Mendes, Z.; Miranda, A.; Bragança, F.; Cristino, J.; Canhão, H.; Branco, J.C.. "Low persistence with oral biphosphonate treatment in postmenopausal osteoporosis,Low persistence with oral biphosphonate treatment in postmenopausal osteoporosis". Acta reumatologica portuguesa 44 2 (2019): 114-125. http://www.scopus.com/inward/record.url?eid=2-s2.0-85071786250&partnerID=MN8TOARS.
  33. Torre, Carla; Cary, Maria; Borges, Fábio Cardoso; Ferreira, Paula S.; Alarcão, Joana; Leufkens, Hubert G.; Costa, João; Martins, Ana Paula. "Intensive monitoring studies for assessing medicines : a systematic review". (2019): http://hdl.handle.net/10451/39830.
    10.3389/fmed.2019.00147
  34. Torre, Carla; Guerreiro, José; Mendes, Zilda; Miranda, Ana; Bragança, Fátima; Cristino, Joaquim; Canhão, Helena; Branco, Jaime. "Low persistence with oral biphosphonate treatment in postmenopausal osteoporosis". (2019): http://www.actareumatologica.pt/archive_detail.php?id=226.
  35. Torre, Carla; Cary, Maria; Borges, Fábio Cardoso; Ferreira, Paula S.; Alarcão, Joana; Leufkens, Hubert G.; Costa, João; Martins, Ana Paula. "Intensive monitoring studies for assessing medicines : a systematic review". (2019): http://hdl.handle.net/10451/39830.
    10.3389/fmed.2019.00147
  36. Torre, Carla; Guerreiro, José; Mendes, Zilda; Miranda, Ana; Bragança, Fátima; Cristino, Joaquim; Canhão, Helena; et al. "Low persistence with oral biphosphonate treatment in postmenopausal osteoporosis". Acta reumatologica portuguesa (2019): http://www.actareumatologica.pt/archive_detail.php?id=226.
  37. Torre, C.; Guerreiro, J.; Mendes, Z.; Miranda, A.; Braganca, F.; Cristino, J.; Canhao, H.; Branco, J.. "Low persistence with oral bisphosphonate treatment in postmenopausal osteoporosis". Acta Reumatologica Portuguesa (2019): https://publons.com/wos-op/publon/2312400/.
  38. Torre C; Guerreiro J; Longo P; Raposo JF; Leufkens H; Martins AP. "Health-related quality of life in adults with type 2 diabetes mellitus starting with new glucose lowering drugs: An inception cohort study.". Primary care diabetes (2018): http://europepmc.org/abstract/med/30573348.
    10.1016/j.pcd.2018.11.009
  39. Torre C; Guerreiro JP; Romano S; Miranda A; Longo P; Alão S; Conceição J; Laires P. "Real-world prevalence of mild to moderate hypoglycemic episodes in type 2 diabetes in Portugal: Results from the HIPOS-PHARMA study.". Primary care diabetes (2018): http://europepmc.org/abstract/med/30017600.
    10.1016/j.pcd.2018.06.001
  40. Torre, Carla; Guerreiro, Jose; Longo, Patricia; Raposo, Joao Filipe; Leufkens, Hubert; Martins, Ana Paula; Torre C; et al. "Effect of different methods for estimating persistence and adherence to new glucose-lowering drugs: results of an observational, inception cohort study in Portugal". Patient preference and adherence (2018): http://hdl.handle.net/10362/55828.
    https://doi.org/10.2147/PPA.S170134
  41. Torre, Carla; Guerreiro, Jose; Longo, Patricia; Raposo, Joao Filipe; Leufkens, Hubert; Martins, Ana Paula. "Intensive monitoring (IM) of new glucose lowering drugs (GLD): Results from an inception cohort study in Portugal using patients as a source of information". Pharmacoepidemiology and Drug Safety (2018): https://publons.com/wos-op/publon/29973190/.
  42. Torre, Carla; Guerreiro, Jose; Longo, Patricia; Raposo, Joao Filipe; Leufkens, Hubert; Martins, Ana Paula. "Health-related quality of life in type 2 diabetes mellitus (T2DM) patients starting with new glucose lowering drugs (GLD): An inception cohort study in Portugal". Pharmacoepidemiology and Drug Safety (2018): https://publons.com/wos-op/publon/29973191/.
  43. Gama H; Torre C; Guerreiro JP; Azevedo A; Costa S; Lunet N. "Use of generic and essential medicines for prevention and treatment of cardiovascular diseases in Portugal.". BMC health services research (2017): http://europepmc.org/abstract/med/28662649.
    10.1186/s12913-017-2401-2
  44. Fernandes, Ricardo M.; Cary, Maria; Duarte, Gonçalo; Jesus, Gonçalo; Alarcão, Joana; Torre, Carla; Costa, Suzete; et al. "Effectiveness of needle and syringe Programmes in people who inject drugs : an overview of systematic reviews". BMC public health (2017): http://hdl.handle.net/10451/32123.
    10.1186/s12889-017-4210-2
  45. Torre, Carla M.; Guerreiro, Jose; Longo, Patricia; Filipe, Helder Mota; Raposo, Joao Filipe; Leufkens, Hubert; Martins, Ana Paula. "Real Life Drug USAGE of New Glucose Lowering Drugs (GLD): Results of an Intensive Monitoring Study in Portugal". Pharmacoepidemiology and Drug Safety (2017): https://publons.com/wos-op/publon/29973193/.
  46. Torre, Carla; Romano, Sonia; Guerreiro, Jose; Longo, Patricia; Miranda, Ana; Conceicao, Joao; Alao, Silvia; Laires, Pedro. "Hypoglycemia in Portugal Study-Pharmacy (HIPOS-PHARMA)". Pharmacoepidemiology and Drug Safety (2017): https://publons.com/wos-op/publon/36158941/.
  47. Torre, C.; Romano, S.; Guerreiro, J. P.; Longo, P.; Miranda, A.; Conceicao, J.; Alao, S.; Laires, P. A.. "REAL-WORLD PREVALENCE OF MILD TO MODERATE HYPOGLYCEMIC EVENTS IN PORTUGAL - RESULTS FROM THE HIPOS-PHARMA STUDY". Value in Health (2017): https://publons.com/wos-op/publon/36158931/.
    10.1016/J.JVAL.2017.08.436
  48. Laires, P. A.; Conceicao, S.; Alao, S.; Guerreiro, J. P.; Romano, S.; Longo, P.; Miranda, A.; Torre, C.. "THE REAL-WORLD IMPACT OF MILD TO MODERATE HYPOGLYCEMIC EVENTS IN PORTUGAL - RESULTS FROM THE HIPOS-PHARMA STUDY". Value in Health (2017): https://publons.com/wos-op/publon/36158933/.
    10.1016/J.JVAL.2017.08.469
  49. Torre, Carla; Brazão, Roberto; Guerreiro, José; Gomes, Marta; Costa, Suzete; Oliveira, Luísa; Viegas, Silvia. "Investigação epidemiológica de toxinfeções alimentares na rede das Farmácias Portuguesas: um estudo-piloto". (2016): http://hdl.handle.net/10400.18/3696.
  50. Torre, Carla; Brazão, Roberto; Guerreiro, José; Gomes, Marta; Costa, Suzete; Oliveira, Luísa; Viegas, Silvia. "Investigação epidemiológica de toxinfeções alimentares na rede das Farmácias Portuguesas: um estudo-piloto". (2016): http://hdl.handle.net/10400.18/3696.
  51. Torre, Carla; Guerreiro, Jose; Longo, Patricia; Costa, Suzete. "Comparison of Glucose Lowering Drugs Usage Between Portugal and 6 European Countries, in 2014". Pharmacoepidemiology and Drug Safety (2016): https://publons.com/wos-op/publon/51988448/.
  52. Gomes, Marta Vargas; Torre, Carla; Guerreiro, Jose; Nogueira, Paulo; Furtado, Cristina. "Association between quality indicator of antibiotic consumption and antimicrobial resistance". International Journal of Clinical Pharmacy (2016): https://publons.com/wos-op/publon/51988446/.
  53. Torre, Carla; Guerreiro, Jose; Longo, Patricia; Leufkens, Hubert; Martins, Ana Paula. "New Glucose Lowering Drugs (Gld) Usage in Portugal: Results of an Intensive Monitoring Study in Real-Life Conditions". Pharmacoepidemiology and Drug Safety (2016): https://publons.com/wos-op/publon/51988447/.
  54. Torre C; Guerreiro J; de Oliveira Martins S; Raposo JF; Martins AP; Leufkens H. "Patterns of glucose lowering drugs utilization in Portugal and in the Netherlands. Trends over time.". Primary care diabetes (2015): http://europepmc.org/abstract/med/25911273.
    10.1016/j.pcd.2015.03.009
  55. Jacinto, Isabel Pimenta; Costa, Suzete; Horta, Maria Rute; Mendes, Zilda; Torre, Carla; Guerreiro, José Pedro; Queirós, Sónia Isabel. "VACCINATION SERVICE IN THE PORTUGUESE PHARMACIES". (2015): https://doi.org/10.25756/rpf.v7i3.13.
    https://doi.org/10.25756/rpf.v7i3.13
  56. Gomes, Marta V.; Torre, Carla; Guerreiro, Jose; Nogueira, Paulo; Furtado, Cristina. "11 years of outpatient antibiotic utilization in Portugal - utilization pattern and regional comparison between 2004 and 2014". Pharmacoepidemiology and Drug Safety (2015): https://publons.com/wos-op/publon/51988449/.
  57. Torre, Carla; Guerreiro, Jose Pedro; Gomes, Marta; Costa, Suzete. "Trends in the consumption of antiepileptic drugs in Portugal, 2004-2014". Pharmacoepidemiology and Drug Safety (2015): https://publons.com/wos-op/publon/51988450/.
  58. Gama, Helena; Torre, Carla; Guerreiro, Jose Pedro; Lima, Maria Joao; Azevedo, Ana; Costa, Suzete; Lunet, Nuno. "Generic and essential medicines towards a more efficient use of resources in the prevention and treatment of cardiovascular diseases in Portugal". Pharmacoepidemiology and Drug Safety (2015): https://publons.com/wos-op/publon/28572249/.
  59. Torre, Carla; Gomes, Marta; Guerreiro, Jose. "Consumption of Rosiglitazone and Pioglitazone Following Safety Warnings - A Time Series Intervention Analysis in Portugal". Pharmacoepidemiology and Drug Safety (2014): https://publons.com/wos-op/publon/51988453/.
  60. Torre, Carla; Guerreiro, Jose; Gomes, Marta; Costa, Suzete. "Do Rational Use Meet Reality in a Country Under Financial Assistance Program for Cost-Saving Expenditures? The Two Sides of the Portuguese Coin". Pharmacoepidemiology and Drug Safety (2014): https://publons.com/wos-op/publon/51988452/.
  61. Torre, Carla; Guerreiro, Jose; Gomes, Marta; Costa, Suzete. "Comparison of Outpatient Antibiotic Use Between Portugal and 5 European Countries in 2012-There Is (Much) Room for Improvement!". Pharmacoepidemiology and Drug Safety (2014): https://publons.com/wos-op/publon/51988451/.
  62. Souto, Diana; Simões, José Augusto; Torre, Carla; Mendes, Zilda; Falcão, Isabel Marinho; Ferreira, Fernando; Miranda, Ana da Costa; et al. "Perfil Terapêutico da Hipertensão na rede Médicos Sentinela : 12 Anos Depois". (2013): http://hdl.handle.net/10400.26/9900.
  63. Souto, Diana; Simões, José Augusto; Torre, Carla; Mendes, Zilda; Falcão, Isabel Marinho; Ferreira, Fernando; Miranda, Ana da Costa; Dias, Carlos Matias. "Prescribing patterns for hypertension in the Portuguese sentinel practice network – 12 years after". (2013): https://doi.org/10.32385/rpmgf.v29i5.11162.
    https://doi.org/10.32385/rpmgf.v29i5.11162
  64. Costa, S.; Guerreiro, J. P.; Baptista, A.; Teixeira, I; Torre, C.. "CROSS-COUNTRY COMPARISON OF PRESCRIBING PATTERNS VERSUS PORTUGAL AND POTENTIAL COST-SAVINGS". Value in Health (2013): https://publons.com/wos-op/publon/51988463/.
    10.1016/J.JVAL.2013.08.1349
  65. Torre, Carla; Guerreiro, Jose; Mendes, Zilda; Miranda, Ana; Canhao, Helena; Branco, Jaime; Machado, Manuela; et al. "Low Persistence with Oral Bisphosphonate Treatment in Portuguese Women with Postmenopausal Osteoporosis". Pharmacoepidemiology and Drug Safety (2013): https://publons.com/wos-op/publon/51988454/.
  66. Torre, Carla; Guerreiro, Jose; Costa, Suzete. "Trends in the Consumption of Antihypertensive Therapy in Portugal, 2004-2011". Pharmacoepidemiology and Drug Safety (2012): https://publons.com/wos-op/publon/51988455/.
  67. Guerreiro, J.; Torre, C.; Mendes, Z.; Machado, M.; Ferreira, I; Feudjo-tepie, M.; Canhao, H.; et al. "EFFECT OF DIFFERENT METHODS ON ESTIMATING PERSISTENCE TO ORAL BISPHOSPHONATE THERAPY IN PORTUGUESE PMO PATIENTS - AN OBSERVATIONAL PROSPECTIVE STUDY". Value in Health (2012): https://publons.com/wos-op/publon/51988462/.
    10.1016/J.JVAL.2012.08.1412
  68. Torre, Carla; Jose, Guerreiro; Costa, Suzete. "Trends in the Consumption of Antidepressants, Anxiolytics, Hypnotics and Sedatives in Portugal, over the National Health Plan Period (2004-2010)". Pharmacoepidemiology and Drug Safety (2011): https://publons.com/wos-op/publon/51988456/.
  69. Torre C; Lucas R; Barros H. "Syringe exchange in community pharmacies--The Portuguese experience.". The International journal on drug policy (2010): http://europepmc.org/abstract/med/20956074.
    10.1016/j.drugpo.2010.09.001
  70. Torre, Carla; Guerreiro, Jose; Costa, Suzete. "Trends in the Consumption and Costs of Oral Antidiabetic Drugs in Portugal, 2004-2009". Pharmacoepidemiology and Drug Safety (2010): https://publons.com/wos-op/publon/51988457/.
  71. Guerreiro, Jose; Torre, Carla; Costa, Suzete. "Trends in the Consumption of Antidepressants in Portugal, 2004-2009". Pharmacoepidemiology and Drug Safety (2010): https://publons.com/wos-op/publon/51988458/.
  72. Torre, C.; Torre,Carla. "Syringe exchange programmes in the context of harm reduction". Arquivos de Medicina 23 3 (2009): 119-131. http://www.scopus.com/inward/record.url?eid=2-s2.0-77649225656&partnerID=MN8TOARS.
Thesis / Dissertation
  1. Almeida, Francisca Rodrigues de. "Access to biologicals and biosimilars: an overview of the european and the north american markets". Master, 2023. http://hdl.handle.net/10451/64401.
  2. Andrade, Ana Sofia Borges Rocha de. "Overview of the EU PAS register postauthorization studies performed in Europe for medicines approved under conditional marketing authorization". Master, 2023. http://hdl.handle.net/10451/64453.
  3. Pereira, Carolina Soares Santos Marques. "Examining the role of market access in the pharmaceutical industry : a scoping review of european practices". Master, 2023. http://hdl.handle.net/10451/64350.
  4. Pereira, Ricardo Manuel Borges. "Genetic testing in breast cancer screening : a scoping review". Master, 2023. http://hdl.handle.net/10451/64121.
  5. Sousa, Martim Pacheco e Silva de. "Economic impact of pharmaceutical care in community setting and hospitals : a systematic review". Master, 2023. http://hdl.handle.net/10451/64452.
  6. Oliveira, Ana Margarida Melo. "The impact of COVID-19 on antimicrobial resistance". Master, 2023. http://hdl.handle.net/10451/64417.
  7. Almeida, Diogo Manuel Monteiro de. "COVID-19 pandemic and the consumption of self-care products for pediculosis capitis in Portugal : an interrupted time-series analysis". Master, 2023. http://hdl.handle.net/10451/64057.
  8. Pereira, Maria Regina Capaz Coelho Baptista. "Envolvimento das Associações de Pessoas que vivem com doença na Farmacovigilância: perceção das Associações de Pessoas que vivem com doença em Portugal sobre o processo de notificação de Reações Adversas a Medicamentos". Master, 2023. http://hdl.handle.net/10451/64054.
  9. Santos, Ana Clara Guerreiro de Oliveira. "Análise do perfil das notificações de suspeitas de reações adversas às vacinas contra a COVID-19 na Unidade de Farmacovigilância de Lisboa, Setúbal e Santarém". Master, 2022. http://hdl.handle.net/10451/57905.
  10. Ribeiro Parracha, Edna. "Pharmacist´s role in flu immunisation:". Master, 2022. http://hdl.handle.net/10451/57909.
  11. Rodrigues, Tiago Guilherme. "Strategies and interventions on responsible and rational use of benzodiazepines and derivates in the treatment of anxiety and sleep disorders". Master, 2022. http://hdl.handle.net/10362/154470.
  12. Sousa, Afonso Rodrigues Medina de. "O Impacto da pandemia no doente diabético em Portugal". Master, 2022. http://hdl.handle.net/10451/57954.
  13. Ribeiro, João Bernardo Lourenço. "Analysis of the collaboration protocols between the Pharmacovigilance Centres of Porto, Coimbra, and Lisboa, Setúbal e Santarém, with the Central Hospitals of these regions". Master, 2022. http://hdl.handle.net/10451/54600.
  14. Branco, Gabriel Costa. "Collection of real-world data at the community pharmacy". Master, 2022. http://hdl.handle.net/10451/63448.
  15. Frutuoso, Daniel Bruno Rainho. "Pneumónica e COVID-19:". Master, 2022. http://hdl.handle.net/10451/57907.
  16. Teixeira, Maria Manuel de Oliveira. "A review of patient-reported outcomes for european medicines agency regulatory approval of oncologic drugs between 2017 and 2020". Master, 2022. http://hdl.handle.net/10451/62948.
  17. Costa, Catarina Rego da. "Factors associated with under-reporting of adverse drug reactions : a systematic review". Master, 2022. http://hdl.handle.net/10451/64892.
  18. António, Ana Pedro. "Methodologies on collection and use of patient experience data for medicines’ regulatory assessment". Master, 2022. http://hdl.handle.net/10451/57982.
  19. Domingues, Mariana Filipa Antunes. "Impact of the COVID-19 pandemic on outpatient medicines use: antibiotics as an example". Master, 2021. http://hdl.handle.net/10451/53081.
  20. Fernandes, Jorge Manuel Rodrigues Morais Varandas. "O desafio e a responsabilidade de comunicar em saúde: a particularidade dos documentos de informação ao participante em investigação clínica". Master, 2021. http://hdl.handle.net/10451/53039.
  21. Borges, Joana Catarina Lopes. "Implementação de planos de prevenção da gravidez (PPG) no âmbito da gestão de risco em Portugal: análise comparativa entre medicamentos". Master, 2021. http://hdl.handle.net/10451/52919.
  22. AL-MUSAWE, LABIB. "Patterns of polypharmacy and potential overtreatment in elderly people with type 2 diabetes mellitus using real-world data". PhD, 2021. http://hdl.handle.net/10451/48528.
  23. Brito, Maria de Fátima Martins; Brito, M.D.F.; Torre, C.; Silva-Lima, B.. "Scientific advances in diabetes: the impact of the innovative medicines initiative". Master, 2020. http://hdl.handle.net/10451/54057.
    10.3389/fmed.2021.688438
  24. Lopes, Diana Catarina dos Santos; Braga, Rita Isabel Estevão. "Contributo dos doentes para a avaliação da relação benefício/risco dos medicamentos na fase pós-comercialização: comparação do perfil de notificação dos doentes e dos profissionais de saúde na terapêutica da esclerose múltipla". Master, 2020. http://hdl.handle.net/10451/52423.
  25. Nieto, Margarida Chinita. "Patients contribution to the benefit/risk assessment of medicines in the post-marketing phase: the role of Portuguese patients’ associations in pharmacovigilance". Master, 2019. http://hdl.handle.net/10451/43308.
  26. Parreira, Ana Isabel de Figueiredo. "Contributo dos doentes para a avaliação da relação benefício/risco dos medicamentos na fase de pós-comercialização". Master, 2019. http://hdl.handle.net/10451/43475.
  27. Gomes, Marta Alexandra Vargas. "Relação entre as resistências aos antibióticos e o consumo de antibióticos em Portugal : uma abordagem ecológica". Master, 2019. http://hdl.handle.net/10451/39441.
  28. Manuel, Amadeu Álvaro. "Estudo das interações medicamentosas em indivíduos internados por hipertensão arterial no Serviço de Medicina Interna do Hospital Geral de Luanda". Master, 2019. http://hdl.handle.net/10451/54801.
  29. Torre, Carla. "Intensive monitoring in Portugal : a pharmacy-based model to assess in real-life conditions : the example of new glucose lowering drugs". PhD, 2018. http://hdl.handle.net/10451/34769.
  30. Crispim, Bernardo Manuel Ribeiro Pereira Simões. "SGLT-2 inhibitors users profile recruited through a pharmacy-based intensive monitoring study: analysis of the pharmacotherapeutic profile, drug-drug interactions, and comparison with the population of the randomized controlled trials". Master, 2017. http://hdl.handle.net/10451/35979.
  31. Furtado, Filipa Magalhães de Moura e Mota. "Monitorização Intensiva de Dolutegravir no Centro Hospitalar Lisboa Ocidental E.P.E., Hospital Egas Moniz". Master, 2017. http://hdl.handle.net/10451/35940.
  32. Torre, Carla Alexandra de Matos. ""Syringe Exchange Programmes - the portuguese experience".". Master, 2011. http://hdl.handle.net/10216/21947.
Activities

Association member

Society Organization name Role
2021 - Current International Society of Pharmacovigilance
2009 - Current International Society of Pharmacoepidemiology
2006 - Current Portuguese Association of Epidemiology Member

Committee member

Activity description
Role 		Institution / Organization
2022/06 - Current Methodology Working Party, European Medicines Agency
Member
 European Medicines Agency, Netherlands
2021/02 - Current Co-opted member (Pharmacoepidemiology) of the Committee for Medicinal Products for Human Use (CHMP), European Medicines Agency
Member
2020/12 - Current Member of the Evaluation Board of Medicines of the Portuguese National Authority of Medicines and Health Products - INFARMED
Member

Consulting

Activity description Institution / Organization
2016 - Current Expert (Pharmacoepidemiology) of the Pharmacovigilance Unit of Lisboa and Setúbal/Santarém